COO
The Cooper Companies, Inc
NASDAQ: COO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$61.34
-2.77% today
Updated 2026-04-29
Market cap
$11.97B
P/E ratio
30.52
P/S ratio
2.88x
EPS (TTM)
$2.01
Dividend yield
—
52W range
$61 – $90
Volume
2.1M
The Cooper Companies, Inc (COO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.35B | $2.56B | $2.59B | $2.55B | $2.53B | $2.62B | $2.94B | $3.14B | $4.46B | $4.46B | $4.48B | $4.86B | $6.11B | $6.27B | $6.74B | $9.61B | $11.49B | $11.66B | $12.32B | $12.39B |
| Cash & equivalents | $8.22M | $3.23M | $1.94M | $3.93M | $3.57M | $5.17M | $12.84M | $77.39M | $25.22M | $16.43M | $100.80M | $88.80M | $77.70M | $89.00M | $115.90M | $95.90M | $138.20M | $120.80M | $107.60M | $110.60M |
| Current assets | $456.95M | $517.52M | $526.03M | $503.88M | $491.34M | $540.35M | $657.86M | $747.24M | $791.62M | $841.82M | $934.46M | $953.20M | $1.09B | $1.16B | $1.27B | $1.47B | $1.53B | $1.70B | $1.95B | $2.11B |
| Total liabilities | $974.09M | $1.14B | $1.17B | $1.01B | $858.24M | $687.03M | $728.23M | $713.77M | $1.87B | $1.79B | $1.78B | $1.68B | $2.81B | $2.65B | $2.91B | $2.66B | $4.32B | $4.11B | $4.23B | $4.16B |
| Current liabilities | $276.63M | $286.48M | $255.41M | $175.41M | $199.52M | $267.21M | $262.55M | $321.25M | $442.18M | $565.42M | $536.46M | $396.10M | $536.50M | $1.11B | $1.00B | $732.10M | $1.28B | $969.00M | $1.02B | $1.11B |
| Long-term debt | $681.29M | $830.12M | $861.78M | $771.63M | $591.98M | $327.45M | $348.42M | $301.67M | $1.28B | $1.11B | $1.11B | $1.15B | $1.99B | $1.26B | $1.38B | $1.40B | $2.35B | $2.52B | $2.55B | $2.46B |
| Shareholder equity | $1.38B | $1.46B | $1.42B | $1.54B | $1.67B | $1.94B | $2.19B | $2.40B | $2.57B | $2.67B | $2.70B | $3.18B | $3.31B | $3.63B | $3.82B | $6.94B | $7.17B | $7.55B | $8.08B | $8.24B |
| Retained earnings | $348.00M | $334.13M | $402.24M | $500.08M | $600.52M | $773.14M | $1.02B | $1.31B | $1.58B | $1.78B | $2.05B | $2.43B | $2.58B | $3.03B | $3.26B | $6.20B | $6.58B | $6.88B | $7.27B | $7.64B |
| Accounts receivable | $146.58M | $164.49M | $159.16M | $170.94M | $197.49M | $214.78M | $234.30M | $229.54M | $276.28M | $282.92M | $291.40M | $316.60M | $374.70M | $435.30M | $435.40M | $515.30M | $557.80M | $609.70M | $717.00M | $829.00M |
| Inventory | $236.51M | $267.91M | $283.45M | $260.85M | $227.90M | $253.58M | $320.20M | $338.92M | $381.47M | $419.69M | $417.70M | $454.10M | $468.80M | $506.90M | $570.40M | $585.60M | $628.70M | $735.60M | $802.70M | $846.00M |
| Goodwill | $1.22B | $1.25B | $1.25B | $1.26B | $1.26B | $1.28B | $1.37B | $1.39B | $2.22B | $2.20B | $2.16B | $2.35B | $2.39B | $2.43B | $2.45B | $2.57B | $3.61B | $3.62B | $3.84B | $3.85B |